<DOC>
	<DOCNO>NCT00588588</DOCNO>
	<brief_summary>The report incidence ventilator associate pneumonia ( VAP ) 10 15 per 1,000 ventilator day . VAP lead excess cost exceed $ 40,000 per patient associate crude mortality rate high 76 % . The clinical criterion diagnosis VAP low specificity may lead unnecessary antibiotic use . The Clinical Pulmonary Infection Score ( CPIS ) bronchoscopic approach low unnecessary antimicrobial use , antimicrobial resistance , superinfection compare traditional clinical criterion . Based available evidence local microbiology data , develop VAP management protocol guide CPIS bronchoalveolar lavage ( BAL ) adult suspect VAP . These two approach compare . Although diagnostic study CPIS guide approach inexpensive easily available , BAL potential minimize unnecessary use antibiotic reduce development drug resistant pathogen . In study , propose test hypothesis BAL lead reduction antibiotic use compare CPIS patient suspect VAP . The study design randomize , clinical trial compare CPIS versus BAL . The primary outcome measure antibiotic utilization . The secondary outcome measure mortality , morbidity , development resistant pathogen superinfection infection relate financial burden . Completion trial help u identify best approach avoid unnecessary antibiotic utilization minimize development resistant pathogen ( associate morbidity mortality ) critically ill patient .</brief_summary>
	<brief_title>Bronchoscopy vs. Clinical Pulmonary Infection Score Guided Approach Suspected Ventilator-Associated Pneumonia ( VAP )</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<criteria>Age &gt; = 18 year Endotracheal intubation Suspected VAP : New progressive pulmonary infiltrates plus two follow ( In patient preexist ALI ARDS , physician ' suspicion VAP two list criterion use . ) : Temperature &gt; 38 C &lt; 36 C , WBC &gt; 12,000/mL &lt; 4,000/mL , purulent endotracheal secretion . Patient legally authorize representative able sign Informed Consent Prison inmate Immunocompromised patient Participation another trial conflict design current trial Previous history VAP hospitalization Previous participation current study Concomitant nonpulmonary infection diagnose within 3 day precede suspected VAP Patient 's primary care provider want subject enrol study Contraindications bronchoscopy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Ventilator associate pneumonia</keyword>
	<keyword>Intensive Care</keyword>
	<keyword>Antibiotics</keyword>
	<keyword>Mortality</keyword>
	<keyword>Length stay</keyword>
</DOC>